Pharmacologic increase in HIF1α enhances hematopoietic stem and progenitor homing and engraftment

Blood

Volumn 123, Issue 2, 2014, Pages 203-207

  Speth, Jennifer M ^a   Hoggatt, Jonathan ^a,b   Singh, Pratibha ^a   Pelus, Louis M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR; CHEMOKINE RECEPTOR CXCR4;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENGRAFTMENT; EX VIVO STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HYPOXIA; MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; METABOLISM; STEM CELL MOBILIZATION;

ANIMALS; DINOPROSTONE; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; RECEPTORS, CXCR4; TRANSCRIPTION, GENETIC;

EID: 84892668014     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-07-516336     Document Type: Article

References (33)

1. Verma DS, Spitzer G, Zander A.R., McCredie KB, Dicke KA Prostaglandin E1-mediated augmentation of human granulocyte-macrophage progenitor cell growth in vitro. Leuk Res. 1981; 5(1): 65-71. (Pubitemid 11154745)
2. Pelus LM. Association between colony forming units-granulocyte macrophage expression of Ia-like (HLA-DR) antigen and control of granulocyte and macrophage production. A new role for prostaglandin E. J Clin Invest. 1982; 70(3): 568-578. (Pubitemid 12054581)
3. North TE, Goessling W, Walkley C.R., et al Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature. 2007; 447(7147): 1007-1011. (Pubitemid 46975751)
4. Goessling W, Allen RS, Guan X, et al Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell. 2011; 8(4): 445-458.
5. Cutler C, Multani P, Robbins D., et al Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood. 2013; 122(17): 3074-3081.
6. Hoggatt J, Singh P, Sampath J., Pelus LM Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 2009; 113(22): 5444-5455.
7. Parmar K, Mauch P, Vergilio J.A., Sackstein R., Down JD Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA. 2007; 104(13): 5431-5436. (Pubitemid 47175697)
8. Simsek T, Kocabas F, Zheng J., et al The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010; 7(3): 380-390.
9. Takubo K, Goda N, Yamada W., et al Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell. 2010; 7(3): 391-402.
10. Wang LD, Wagers AJ Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol. 2011; 12(10): 643-655.
11. Winkler IG, Barbier V, Wadley R., Zannettino AC, Williams S, Lévesque JP. Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches. Blood. 2010; 116(3): 375-385.
12. Nombela-Arrieta C., Pivarnik G, Winkel B., et al Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat Cell Biol. 2013; 15(5): 533-543.
13. Eliasson P, Rehn M, Hammar P., et al Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture. Exp Hematol. 2010; 38(4): 301-310, e2.
14. Harris JM, Esain V, Frechette G.M., et al Glucose metabolism impacts the spatiotemporal onset and magnitude of HSC induction in vivo. Blood. 2013; 121(13): 2483-2493.
15. Ishikawa T, Nakashiro K, Klosek S.K., et al Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol Rep. 2009; 21(3): 707-712.
16. Pore N, Maity A. The chemokine receptor CXCR4: a homing device for hypoxic cancer cells? Cancer Biol Ther. 2006; 5(11): 1563-1565.
17. Schioppa T, Uranchimeg B, Saccani A., et al Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 2003; 198(9): 1391-1402. (Pubitemid 37392484)
18. Staller P, Sulitkova J, Lisztwan J., Moch H, Oakeley EJ, Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature. 2003; 425(6955): 307-311. (Pubitemid 37158407)
19. Wang X, Li C, Chen Y., et al Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem Biophys Res Commun. 2008; 371(2): 283-288.
20. Zagzag D, Lukyanov Y, Lan L., et al Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest. 2006; 86(12): 1221-1232. (Pubitemid 44789912)
21. Fernández-Martínez AB, Jiménez MI, Manzano VM, Lucio-Cazaña FJ. Intracrine prostaglandin E(2) signalling regulates hypoxia-inducible factor-1α expression through retinoic acid receptor-β. Int J Biochem Cell Biol. 2012; 44(12): 2185-2193.
22. Liu XH, Kirschenbaum A, Lu M., et al Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. J Biol Chem. 2002; 277(51): 50081-50086. (Pubitemid 36014461)
23. Palayoor ST, Tofilon PJ, Coleman CN Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Clin Cancer Res. 2003; 9(8): 3150-3157. (Pubitemid 37006311)
24. Ivan M, Haberberger T, Gervasi D.C., et al Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA. 2002; 99(21): 13459-13464. (Pubitemid 35215403)
25. Kamura T, Sato S, Iwai K., Czyzyk-Krzeska M, Conaway RC, Conaway JW Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA. 2000; 97(19): 10430-10435.
26. Maxwell PH, Wiesener MS, Chang G.W., et al The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733): 271-275. (Pubitemid 29246458)
27. Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 1997; 272(36): 22642-22647. (Pubitemid 27386079)
28. Kaluz S, Kaluzová M, Stanbridge EJ. Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta. 2008; 395(1-2): 6-13.
29. Watson AJ, Weir-Brown KI, Bannister R.M., et al Mechanism of action of a repressor of dioxin-dependent induction of Cyp1a1 gene transcription. Mol Cell Biol. 1992; 12(5): 2115-2123.
30. Takabuchi S, Hirota K, Nishi K., et al The inhibitory effect of sodium nitroprusside on HIF-1 activation is not dependent on nitric oxide-soluble guanylyl cyclase pathway. Biochem Biophys Res Commun. 2004; 324(1): 417-423. (Pubitemid 39311511)
31. Sogawa K, Numayama-Tsuruta K, Ema M., Abe M, Abe H, Fujii-Kuriyama Y. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci USA. 1998; 95(13): 7368-7373. (Pubitemid 28293258)
32. Roy S, Tripathy M, Mathur N., Jain A, Mukhopadhyay A. Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency. Eur J Haematol. 2012; 88(5): 396-405.
33. Forristal CE, Winkler IG, Nowlan B, Barbier V., Walkinshaw G, Levesque JP Pharmacologic stabilization of HIF-1α increases hematopoietic stem cell quiescence in vivo and accelerates blood recovery after severe irradiation. Blood. 2013; 121(5): 759-769.